JP2024539079A5 - - Google Patents

Info

Publication number
JP2024539079A5
JP2024539079A5 JP2024523266A JP2024523266A JP2024539079A5 JP 2024539079 A5 JP2024539079 A5 JP 2024539079A5 JP 2024523266 A JP2024523266 A JP 2024523266A JP 2024523266 A JP2024523266 A JP 2024523266A JP 2024539079 A5 JP2024539079 A5 JP 2024539079A5
Authority
JP
Japan
Prior art keywords
binding molecule
sequence
amino acid
nucleic acid
car
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024523266A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024539079A (ja
Filing date
Publication date
Priority claimed from GBGB2114938.0A external-priority patent/GB202114938D0/en
Application filed filed Critical
Publication of JP2024539079A publication Critical patent/JP2024539079A/ja
Publication of JP2024539079A5 publication Critical patent/JP2024539079A5/ja
Pending legal-status Critical Current

Links

JP2024523266A 2021-10-19 2022-10-19 Ｈｅｒ２バリアントｃａｒ Pending JP2024539079A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB2114938.0A GB202114938D0 (en) 2021-10-19 2021-10-19 Her2 variant car
GB2114938.0 2021-10-19
PCT/EP2022/079110 WO2023067007A1 (en) 2021-10-19 2022-10-19 Her2 variant car

Publications (2)

Publication Number Publication Date
JP2024539079A JP2024539079A (ja) 2024-10-28
JP2024539079A5 true JP2024539079A5 (cg-RX-API-DMAC7.html) 2025-10-10

Family

ID=78718395

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024523266A Pending JP2024539079A (ja) 2021-10-19 2022-10-19 Ｈｅｒ２バリアントｃａｒ

Country Status (7)

Country Link
US (1) US20240398949A1 (cg-RX-API-DMAC7.html)
EP (1) EP4419133A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024539079A (cg-RX-API-DMAC7.html)
KR (1) KR20240099303A (cg-RX-API-DMAC7.html)
CN (1) CN118382455A (cg-RX-API-DMAC7.html)
GB (1) GB202114938D0 (cg-RX-API-DMAC7.html)
WO (1) WO2023067007A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025147472A1 (en) * 2024-01-02 2025-07-10 Phanes Therapeutics, Inc. Anti-611-ctf p95her2 antibodies and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3915576A1 (en) * 2020-05-28 2021-12-01 Fundació Privada Institut d'Investigació Oncològica de Vall-Hebron Chimeric antigen receptors specific for p95her2 and uses thereof

Similar Documents

Publication Publication Date Title
JP7150880B2 (ja) 抗－ｂ７－ｈ３抗体およびその用途
JP7295146B2 (ja) 抗－ｒｏｒ１抗体およびその用途
JP7000660B2 (ja) Ｒｏｒ１抗体組成物及び関連の方法
CN109843927B (zh) 抗b7-h3抗体、其抗原结合片段及其医药用途
JP6606505B2 (ja) 抗ＳＩＲＰα抗体および二重特異性マクロファージ増強抗体
JP2026001061A (ja) 抗ｄｌｌ３キメラ抗原受容体及びその使用
JP2021526816A (ja) Ｄｌｌ３−ｃｄ３二重特異性抗体
JP2019116474A5 (cg-RX-API-DMAC7.html)
JP2020525032A5 (cg-RX-API-DMAC7.html)
AU2018218753A1 (en) Anti-GPRC5D antibody and molecule containing same
JP7820383B2 (ja) グリピカン－３およびｔ細胞受容体を標的とする免疫グロブリン単一可変ドメインを含むポリペプチド
JP2018532383A5 (cg-RX-API-DMAC7.html)
JP2019527553A5 (cg-RX-API-DMAC7.html)
WO2018137576A1 (zh) 抗pd-1单克隆抗体及其制备方法和应用
JP2019513370A5 (cg-RX-API-DMAC7.html)
JP2022542543A5 (cg-RX-API-DMAC7.html)
KR20220012313A (ko) 항-ror1/항-cd3 이중특이적 결합 분자
CA3196809A1 (en) Combination treatment
EP3405494A1 (en) Ror2 antibody compositions and related methods
JP2021521793A5 (cg-RX-API-DMAC7.html)
CN108948194B (zh) 一种新的ctla-4单克隆抗体
WO2017072366A1 (en) Anti-mesothelin antibodies
JP7821159B2 (ja) Ｂｃｍａと結合する単一可変ドメイン及び抗原結合分子
JP2018522888A5 (cg-RX-API-DMAC7.html)
JP2024001073A5 (cg-RX-API-DMAC7.html)